{
  "success": true,
  "pagesUsed": [
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    19,
    20,
    22,
    23,
    24,
    25,
    26,
    27,
    28,
    29,
    30,
    31,
    32,
    33,
    34,
    35,
    36,
    37,
    38,
    39,
    40,
    41,
    42,
    43,
    44,
    45,
    46,
    47,
    48,
    49
  ],
  "modelUsed": "gemini-3-flash-preview",
  "interventions": {
    "studyInterventions": [
      {
        "id": "int_1",
        "name": "LY900018",
        "type": {
          "id": "443101b7-aa2b-4ec4-88dc-0677a48330bf",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "role": {
          "id": "ed571a5a-e9d2-4b11-9c35-9900a1bb967d",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Nasal glucagon powder formulation for the rescue treatment of hypoglycemia.",
        "productIds": [
          "prod_1"
        ],
        "administrationIds": [
          "admin_1"
        ]
      },
      {
        "id": "int_2",
        "name": "GlucaGen",
        "type": {
          "id": "2750c695-987b-4857-887b-57a715d662aa",
          "code": "C54129",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Comparator",
          "instanceType": "Code"
        },
        "role": {
          "id": "b9272948-f1b4-4d33-8516-dc043ffa7b9c",
          "code": "C54129",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Comparator",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Intramuscular (IM) glucagon requiring reconstitution prior to administration.",
        "productIds": [
          "prod_2"
        ],
        "administrationIds": [
          "admin_2"
        ]
      },
      {
        "id": "int_3",
        "name": "Human regular insulin",
        "type": {
          "id": "96a1f205-4182-4bcf-a895-9ace62d8ce57",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "role": {
          "id": "fa8bacde-9383-4ce8-b2d7-bc3197aae839",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Used for controlled insulin-induced hypoglycemia procedure (0.3 U/mL).",
        "administrationIds": [
          "admin_3"
        ]
      },
      {
        "id": "int_4",
        "name": "Intravenous (IV) glucose",
        "type": {
          "id": "4a953457-6f5b-4859-972b-491ffd2db404",
          "code": "C54125",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Rescue Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "90eb63b5-a5e4-4fe3-b06d-d4a6251a6582",
          "code": "C54125",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Rescue Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Administered if the patient experiences signs of severe hypoglycemia or insufficient response to glucagon."
      },
      {
        "id": "int_5",
        "name": "Acetaminophen",
        "type": {
          "id": "d4b46fb4-35d3-40c5-bcf4-b74ee4671f21",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "254ce344-e0c1-4347-bfb9-dc805b39133e",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Permitted for treatment of headaches (1 g, max 2 g/24 hours)."
      },
      {
        "id": "int_6",
        "name": "Beta-blockers",
        "type": {
          "id": "014777ba-ef12-4cc5-a204-01061f2684be",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "9512544e-f8cc-4100-9038-84da67e72c39",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Prohibited medication."
      },
      {
        "id": "int_7",
        "name": "Indomethacin",
        "type": {
          "id": "c78077af-c637-4548-ab8e-5b73a66ec99a",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "e52abed7-db46-45eb-8252-86ebf24095bd",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Prohibited medication."
      },
      {
        "id": "int_8",
        "name": "Warfarin",
        "type": {
          "id": "093a4a33-8dbf-4da4-9c6f-e17a4aa372e1",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "7dac4389-8891-4444-ad69-3ad51efc592a",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Prohibited medication."
      },
      {
        "id": "int_9",
        "name": "Anti-cholinergic drugs",
        "type": {
          "id": "ccfc1153-7753-4b18-82d5-201cb5b682b4",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "c5767d95-f42a-4f9d-8c05-276c7d2f11b0",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Prohibited medication."
      },
      {
        "id": "int_10",
        "name": "Pro-motility medications",
        "type": {
          "id": "87376d4c-5924-4468-9318-c95300695dc6",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "25380693-9862-468f-8d84-c156b52e2538",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Must be washed out 7 days before each period (e.g., metoclopramide, domperidone)."
      }
    ],
    "administrableProducts": [
      {
        "id": "prod_1",
        "name": "LY900018",
        "administrableDoseForm": {
          "id": "5f4d9d86-27fe-4ad2-8e6e-9c1292a1640a",
          "code": "C42970",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Powder",
          "standardCode": {
            "id": "0dd9d412-b430-423b-91a6-b20d79039d32",
            "code": "C42970",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Powder",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "e7685f12-e43b-464c-af01-b6c2904f6a5a",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "3 mg",
        "substanceIds": [
          "sub_1"
        ],
        "manufacturer": "Eli Lilly and Company"
      },
      {
        "id": "prod_2",
        "name": "GlucaGen",
        "administrableDoseForm": {
          "id": "e4e58bca-837f-4ffa-b724-56ebf2e93b6c",
          "code": "C42970",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Powder",
          "standardCode": {
            "id": "c617fb22-c552-40e3-a18a-913d6b5d25d3",
            "code": "C42970",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Powder",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "864d7d78-2a3d-4094-8d20-a22e206a8e6e",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "1 mg",
        "substanceIds": [
          "sub_2"
        ],
        "manufacturer": "Novo Nordisk A/S"
      }
    ],
    "administrations": [
      {
        "id": "admin_1",
        "name": "LY900018 Nasal Administration",
        "instanceType": "Administration",
        "dose": "3 mg",
        "doseFrequency": "Single dose",
        "route": {
          "code": "Other",
          "codeSystem": "USDM",
          "decode": "Other"
        },
        "duration": "Single administration per period"
      },
      {
        "id": "admin_2",
        "name": "GlucaGen IM Injection",
        "instanceType": "Administration",
        "dose": "1 mg",
        "doseFrequency": "Single dose",
        "route": {
          "code": "Intramuscular",
          "codeSystem": "USDM",
          "decode": "Intramuscular"
        },
        "duration": "Single administration per period"
      },
      {
        "id": "admin_3",
        "name": "Insulin Infusion",
        "instanceType": "Administration",
        "dose": "2 to 4 mU/kg/min",
        "doseFrequency": "Continuous infusion",
        "route": {
          "code": "Intravenous",
          "codeSystem": "USDM",
          "decode": "Intravenous"
        },
        "duration": "Until plasma glucose reaches <60 mg/dL (max 4 hours)"
      }
    ],
    "substances": [
      {
        "id": "sub_1",
        "name": "Glucagon",
        "instanceType": "Substance",
        "description": "Synthetic single-chain, 29-amino-acid polypeptide identical to human glucagon."
      },
      {
        "id": "sub_2",
        "name": "Human regular insulin",
        "instanceType": "Substance",
        "description": "Used for hypoglycemia induction."
      }
    ],
    "medicalDevices": [
      {
        "id": "dev_1",
        "name": "Nasal dosing device",
        "instanceType": "MedicalDevice",
        "manufacturer": "Eli Lilly and Company"
      }
    ],
    "summary": {
      "interventionCount": 10,
      "productCount": 2,
      "deviceCount": 1
    }
  },
  "rawResponse": {
    "interventions": [
      {
        "name": "LY900018",
        "role": "Investigational Product",
        "description": "Nasal glucagon powder formulation for the rescue treatment of hypoglycemia."
      },
      {
        "name": "GlucaGen",
        "role": "Comparator",
        "description": "Intramuscular (IM) glucagon requiring reconstitution prior to administration."
      },
      {
        "name": "Human regular insulin",
        "role": "Background Therapy",
        "description": "Used for controlled insulin-induced hypoglycemia procedure (0.3 U/mL)."
      },
      {
        "name": "Intravenous (IV) glucose",
        "role": "Rescue Medication",
        "description": "Administered if the patient experiences signs of severe hypoglycemia or insufficient response to glucagon."
      },
      {
        "name": "Acetaminophen",
        "role": "Concomitant Medication",
        "description": "Permitted for treatment of headaches (1 g, max 2 g/24 hours)."
      },
      {
        "name": "Beta-blockers",
        "role": "Concomitant Medication",
        "description": "Prohibited medication."
      },
      {
        "name": "Indomethacin",
        "role": "Concomitant Medication",
        "description": "Prohibited medication."
      },
      {
        "name": "Warfarin",
        "role": "Concomitant Medication",
        "description": "Prohibited medication."
      },
      {
        "name": "Anti-cholinergic drugs",
        "role": "Concomitant Medication",
        "description": "Prohibited medication."
      },
      {
        "name": "Pro-motility medications",
        "role": "Concomitant Medication",
        "description": "Must be washed out 7 days before each period (e.g., metoclopramide, domperidone)."
      }
    ],
    "products": [
      {
        "name": "LY900018",
        "doseForm": "Dry powder",
        "strength": "3 mg",
        "manufacturer": "Eli Lilly and Company"
      },
      {
        "name": "GlucaGen",
        "doseForm": "Dry powder",
        "strength": "1 mg",
        "manufacturer": "Novo Nordisk A/S"
      }
    ],
    "substances": [
      {
        "name": "Glucagon",
        "description": "Synthetic single-chain, 29-amino-acid polypeptide identical to human glucagon."
      },
      {
        "name": "Human regular insulin",
        "description": "Used for hypoglycemia induction."
      }
    ],
    "administrations": [
      {
        "name": "LY900018 Nasal Administration",
        "dose": "3 mg",
        "frequency": "Single dose",
        "route": "Nasal",
        "duration": "Single administration per period"
      },
      {
        "name": "GlucaGen IM Injection",
        "dose": "1 mg",
        "frequency": "Single dose",
        "route": "Intramuscular",
        "duration": "Single administration per period"
      },
      {
        "name": "Insulin Infusion",
        "dose": "2 to 4 mU/kg/min",
        "frequency": "Continuous infusion",
        "route": "Intravenous",
        "duration": "Until plasma glucose reaches <60 mg/dL (max 4 hours)"
      }
    ],
    "devices": [
      {
        "name": "Nasal dosing device",
        "manufacturer": "Eli Lilly and Company",
        "purpose": "Single-use device to deliver 3 mg glucagon powder for absorption through the nasal mucosa."
      }
    ]
  }
}